SARS-CoV-2 NSP13 antibody (C-Term)
-
- Target See all SARS-CoV-2 NSP13 (HEL) Antibodies
- SARS-CoV-2 NSP13 (HEL) (SARS-CoV-2 Helicase (NSP13) (HEL))
-
Binding Specificity
- C-Term
- Reactivity
- SARS Coronavirus-2 (SARS-CoV-2)
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This SARS-CoV-2 NSP13 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Cross-Reactivity (Details)
- Reacts with SARS-CoV-2 protein
- Purification
- Epitope affinity purified
- Immunogen
- Affinity purified recombinant fusion protein using the C-terminal of Nsp13 (residues 500 to stop) and produced in E. coli.
- Isotype
- IgG
-
-
- Application Notes
- WB:1:500-1:2,000
- Comment
-
In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
- Restrictions
- For Research Use only
-
- Concentration
- 3 mg/mL
- Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at -20 °C for long-term storage. Store at 2-8 °C for up to one month.
-
- Target
- SARS-CoV-2 NSP13 (HEL) (SARS-CoV-2 Helicase (NSP13) (HEL))
- Alternative Name
- NSP13 (SARS-CoV-2) (HEL Products)
- Synonyms
- pp1ab antibody, ORF1a polyprotein;ORF1ab polyprotein antibody, ORF1ab antibody
-